Prostate cancer is the most common form of cancer in men in Germany with more than 65,000 new cases per year. The relative 5- and 10-year survival rates for localized prostate cancer are promising with 89% and 88%, respectively, but depend on the initial tumor stage. The most common curative treatment modality is surgical removal of the prostate (radical prostatectomy). A relevant proportion of men with prostate cancer suffer from urinary incontinence and sexual dysfunction after radical prostatectomy. These are associated with impairments in health-related quality of life and psychological distress.

The PRO-P project aims to investigate how an intensified symptom monitoring using electronic patient-reported outcome measures (ePROMs), which are linked to subsequent actions, affects the postoperative course in men with prostate cancer. The project is planned as a multicenter, prospective, and two-arm randomized control trial in which PROMs are collected in a standardized manner once before and six times (intervention group) or three times (control group) after radical prostatectomy in patients with prostate cancer.

Involved Institutions
Heinrich-Heine-Universität Düsseldorf, Universitätsklinikum (UK) Düsseldorf, Urologische Klinik
Universitätsklinikum Düsseldorf, Klin. Institut für Psychosomatische Medizin und Psychotherapie
UK der Ruhr-Universität Bochum, Klinik für Urologie und Neuro-Urologie, Herne
UK Bonn, Klinik und Poliklinik für Urologie und Kinderurologie
Klinikum Dortmund gGmbH, Urologische Klinik
UK Essen, Klinik und Poliklinik für Urologie, Uroonkologie und Kinderurologie
UK Münster, Klinik für Urologie und Kinderurologie
Universität zu Köln, Lehrstuhl Versorgungsforschung,
Institut für Medizinsoziologie, Versorgungsforschung und Rehabilitationswissenschaft (IMVR)
German Cancer Society (DKG)
Universität zu Köln, Institut für Medizinische Statistik und Bioinformatik
Techniker Krankenkasse

Innovation Committee of The Federal Joint Committee (G-BA)

April 2022 – March 2025

see publications

PD Dr. rer. medic. Christoph Kowalski